Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy

scientific article published on 9 June 2010

Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1210/JC.2010-0340
P698PubMed publication ID20534758

P50authorAlan SchwartzQ37831141
Andrea TinelliQ42335546
Roberto NegroQ43037215
Alex Stagnaro-GreenQ43037232
P2093author name stringRiccardo Gismondi
Tiziana Mangieri
P433issue9
P407language of work or nameEnglishQ1860
P921main subjecthuman pregnancyQ11995
miscarriageQ28693
antibodyQ79460
P304page(s)E44-8
P577publication date2010-06-09
P1433published inThe Journal of Clinical Endocrinology and MetabolismQ3186902
P1476titleIncreased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy
P478volume95

Reverse relations

cites work (P2860)
Q339441242014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children.
Q90014943A hidden cause of infertility in hypothyroid patients
Q35646920A national survey on public perceptions of miscarriage.
Q40227828Association between the clinical classification of hypothyroidism and reduced TSH in LT4 supplemental replacement treatment for pregnancy in China
Q52571440Circulating MicroRNA Profile as a Potential Predictive Biomarker for Early Diagnosis of Spontaneous Abortion in Patients With Subclinical Hypothyroidism.
Q37668431Correlation of enhanced oxidative stress with altered thyroid profile: Probable role in spontaneous abortion
Q38990879Current challenges in the pharmacological management of thyroid dysfunction in pregnancy.
Q46908515Do elevated TSH levels predict early pregnancy loss in ART patients?
Q36084882Early Phthalates Exposure in Pregnant Women Is Associated with Alteration of Thyroid Hormones
Q47161714Early pregnancy thyroid hormone reference ranges in Chilean women: the influence of body mass index.
Q58748644Effect of mildly elevated thyroid-stimulating hormone during the first trimester on adverse pregnancy outcomes
Q92757636Effect of moderately increased thyroid-stimulating hormone levels and presence of thyroid antibodies on pregnancy among infertile women
Q37081142Effects of Levothyroxine Therapy on Pregnancy Outcomes in Women with Subclinical Hypothyroidism
Q50940268Effects of perfluorinated chemicals on thyroid function, markers of ovarian reserve, and natural fertility.
Q36794012Endocrine dysfunction and recurrent spontaneous abortion: An overview
Q44837970Establishing trimester-specific maternal thyroid function reference intervals
Q53629364Etiology of spontaneous abortion before and after the demonstration of embryonic cardiac activity in women with recurrent spontaneous abortion.
Q35622811Feto-maternal Outcome Using New Screening Criteria of Serum TSH for Diagnosing Hypothyroidism in Pregnancy
Q92130873Five serum fatty acids are associated with subclinical hypothyroidism in a Chinese pregnant population
Q35738765Further evidence on the role of thyroid autoimmunity in women with recurrent miscarriage
Q24628836Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum
Q36930719High prevalence of subclinical hypothyroidism during first trimester of pregnancy in North India
Q49617213Higher TSH Levels Within the Normal Range Are Associated With Unexplained Infertility
Q35967753Hypothyroidism in pregnancy
Q87429515Hypothyroidism in pregnancy
Q48267677Impact of borderline-subclinical hypothyroidism on subsequent pregnancy outcome in women with unexplained recurrent pregnancy loss.
Q64095758Impact of subclinical hypothyroidism and thyroid autoimmunity on clinical pregnancy rate after intrauterine insemination in euthyroid women
Q64929751Implantation failure in rats with subclinical hypothyroidism is associated with LIF/STAT3 signaling.
Q57170489Influencing factors of pregnancy loss and survival probability of clinical pregnancies conceived through assisted reproductive technology
Q87038402Knowledge, attitudes and behaviors of physicians towards thyroid disorders and iodine requirements in pregnancy
Q35184548Levothyroxine treatment in pregnancy: indications, efficacy, and therapeutic regimen.
Q26765262Levothyroxine treatment of mild subclinical hypothyroidism: a review of potential risks and benefits
Q36767568Local and systemic factors and implantation: what is the evidence?
Q37290825Management of subclinical hypothyroidism: the thyroidologists' view
Q90125633Maternal TSH levels at first trimester and subsequent spontaneous miscarriage: a nested case-control study
Q94464326Maternal Thyroid Dysfunction and Gestational Anemia Risk: Meta-Analysis and New Data
Q37286956Maternal screening for hypothyroidism and thyroiditis using filter paper specimens
Q34499870Maternal subclinical hypothyroidism, thyroid autoimmunity, and the risk of miscarriage: a prospective cohort study
Q40845746Maternal thyroid function in pregnancy may program offspring blood pressure, but not adiposity at 20 y of age.
Q58612268Meta-analysis of ART outcomes in women with different preconception TSH levels
Q34784972New insights into mechanisms behind miscarriage
Q92215271Novel high-coverage targeted metabolomics method (SWATHtoMRM) for exploring follicular fluid metabolome alterations in women with recurrent spontaneous abortion undergoing in vitro fertilization
Q38247059Optimal management of hypothyroidism, hypothyroxinaemia and euthyroid TPO antibody positivity preconception and in pregnancy.
Q30234769Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: A systematic review and meta-analysis
Q40221860Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure
Q42138515Postpartum Follow-up in Women Diagnosed with Subclinical Hypothyroidism during Pregnancy
Q38906859Preconception TSH and pregnancy outcomes: a population-based cohort study in 184 611 women.
Q64083160Pregnancy Loss and Iodine Status: The LIFE Prospective Cohort Study
Q38191709Pregnancy after definitive treatment for Graves' disease--does treatment choice influence outcome?
Q33815541Prevalence of Thyroid Peroxidase Antibody and Pregnancy Outcome in Euthyroid Autoimmune Positive Pregnant Women from a Tertiary Care Center in Haryana
Q55471416Prevalence of subclinical hypothyroidism in pregnancy in Saudi Arabia.
Q83386958Re-thinking the definitions of subclinical thyroid disease in pregnancy
Q36697714Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG (S1-Level, AWMF Registry No. 015/050, December 2013).
Q51300684Reduction of miscarriages through universal screening and treatment of thyroid autoimmune diseases.
Q57825128Reference intervals for thyroid markers in early pregnancy determined by 7 different analytical systems
Q26768622Reporting Thyroid Function Tests in Pregnancy
Q38300824Reversible morbidity markers in subclinical hypothyroidism
Q51785954Screening for thyroid dysfunction during the second trimester of pregnancy.
Q48271628Secondary and tertiary preventions of thyroid disease
Q38535361Should all women be screened for thyroid dysfunction in pregnancy?
Q36965286Subclinical Hypothyroidism and Thyroid Autoimmunity Are Not Associated With Fecundity, Pregnancy Loss, or Live Birth
Q35912431Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis
Q55054302Subclinical Hypothyroidism in Women Planning Conception and During Pregnancy: Who Should Be Treated and How?
Q36657473Subclinical hypothyroidism in pregnancy: An emerging problem in Southern West Bengal: A cross-sectional study
Q53174703TSH reference values in the first trimester of gestation and correlation between maternal TSH and obstetric and neonatal outcomes: a prospective Brazilian study.
Q34294814Teratology public affairs committee position paper: iodine deficiency in pregnancy
Q37837503The TSH upper reference limit: where are we at?
Q37360481The debate on treating subclinical hypothyroidism
Q38835277The effect of oil and water-soluble contrast medium in hysterosalpingography on thyroid function
Q47100356The impact of elevated thyroid stimulating hormone on female subfertility
Q35646080The impact of thyroid function and thyroid autoimmunity on embryo quality in women with low functional ovarian reserve: a case-control study
Q37689167The impact of thyroid function on intrauterine insemination outcome--a retrospective analysis
Q38056040Thyroid (dys-)function in normal and disturbed pregnancy
Q40492427Thyroid Allostasis-Adaptive Responses of Thyrotropic Feedback Control to Conditions of Strain, Stress, and Developmental Programming.
Q55315584Thyroid Function in Pregnant Women With Moderate to Severe Alcohol Consumption Is Related to Infant Developmental Outcomes.
Q35038902Thyroid antibodies and miscarriage: where are we at a generation later?
Q59742907Thyroid disorders in pregnancy
Q34289817Thyroid function in pregnancy
Q90738081Thyroid hormone therapy of hypothyroidism in pregnancy
Q22305857Treatment for primary hypothyroidism: current approaches and future possibilities
Q33598465Triiodothyronine regulates angiogenic growth factor and cytokine secretion by isolated human decidual cells in a cell-type specific and gestational age-dependent manner.
Q38530405Unsolved Mysteries of the Human Mammary Gland: Defining and Redefining the Critical Questions from the Lactation Consultant's Perspective
Q36284454Urinary iodine in early pregnancy is associated with subclinical hypothyroidism in Tianjin, China: an observational study

Search more.